THORACIC AND CARDIOVASCULAR SURGEON, cilt.63, sa.1, ss.39-44, 2015 (SCI-Expanded)
Background The use of blood products is not uncommon during cardiac surgery in elderly patients. We conducted this study to investigate the risk factors and adverse outcomes of increased red blood cell (RBC) transfusion in the patients aged >= 65 years undergoing cardiac surgery.